NCI/NIH Pain Consortium Science Writers' Seminar

October 12, 2005

What: National Cancer Institute/NIH Pain Consortium Science Writers' Seminar

Chronic pain from conditions like arthritis, migraines, injuries and cancer affects millions of people worldwide, depriving them of their well-being and productivity. While existing drugs and other therapies can ease discomfort for some people, new approaches are needed to help those who still suffer. This seminar will introduce reporters to some of the latest therapies for pain, including a technique that has been dubbed a molecular scalpel. Leaders in the field of pain management will present their research, and a cancer patient will discuss her experience living with severe chronic pain.

Who: When: Wednesday, November 2, 2005, from 11 a.m. - 1:30 p.m.

Join us for talks that will begin at 11 a.m., followed by a light lunch served at noon. Additional talks and a Q&A session will conclude by 1:30 p.m.

Where: NIH Campus, Natcher Conference Center, Room E1/E2, Bethesda, Md.

Attendees are strongly encouraged to use Metro. The NIH campus can be easily accessed via the Medical Center stop on the Metro's Red Line. For transportation, parking and security at NIH, go to http://www.nih.gov/about/visitorsecurity.htm.

How: To register for the press briefing, please contact Dorie Hightower or Ann Benner in the NCI Media Relations Branch at (301) 496-6641 or at ncipressofficers@mail.nih.gov.

For More Information:http://painconsortium.nih.gov/ or www.cancer.gov
-end-


NIH/National Cancer Institute

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.